New hope for ulcerative colitis patients with stubborn gut inflammation
Disease control
Completed
This study tested whether the drug mirikizumab can help people with moderate to severe ulcerative colitis whose gut inflammation has not improved with standard treatments. About 100 adults took part, and researchers measured changes in symptoms and inflammation using colonoscopie…
Phase: PHASE4 • Sponsor: Showa Inan General Hospital • Aim: Disease control
Last updated May 11, 2026 20:41 UTC